Trial Outcomes & Findings for Descemet Endothelial Thickness Comparison Trial (NCT NCT02373137)

NCT ID: NCT02373137

Last Updated: 2020-11-25

Results Overview

The BSCVA was recorded at 4 meters by a masked refractionist certified for the study using a protocol adapted from the Age-Related Eye Disease Study using Early Treatment Diabetic Retinopathy Study charts: chart R(2110), chart 1(2111), and chart 2(2112) (Precision Vision, Woodstock, IL).

Recruitment status

UNKNOWN

Study phase

PHASE4

Target enrollment

38 participants

Primary outcome timeframe

6 months

Results posted on

2020-11-25

Participant Flow

Unit of analysis: eyes

Participant milestones

Participant milestones
Measure
UT-DSAEK
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Overall Study
STARTED
19 25
19 25
Overall Study
3-Month Follow-Up
19 25
19 25
Overall Study
6-Month Follow-Up
19 25
18 24
Overall Study
12-Month Follow-Up
19 25
19 25
Overall Study
COMPLETED
18 24
18 23
Overall Study
NOT COMPLETED
1 1
1 2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

missing one value

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
UT-DSAEK
n=25 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Total
n=50 eyes
Total of all reporting groups
Age, Continuous
68 years
n=25 eyes
68 years
n=25 eyes
68 years
n=50 eyes
Sex: Female, Male
Female
16 eyes
n=25 eyes
13 eyes
n=25 eyes
29 eyes
n=50 eyes
Sex: Female, Male
Male
9 eyes
n=25 eyes
12 eyes
n=25 eyes
21 eyes
n=50 eyes
Race (NIH/OMB)
American Indian or Alaska Native
0 eyes
n=25 eyes
0 eyes
n=25 eyes
0 eyes
n=50 eyes
Race (NIH/OMB)
Asian
1 eyes
n=25 eyes
1 eyes
n=25 eyes
2 eyes
n=50 eyes
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 eyes
n=25 eyes
0 eyes
n=25 eyes
0 eyes
n=50 eyes
Race (NIH/OMB)
Black or African American
0 eyes
n=25 eyes
0 eyes
n=25 eyes
0 eyes
n=50 eyes
Race (NIH/OMB)
White
24 eyes
n=25 eyes
24 eyes
n=25 eyes
48 eyes
n=50 eyes
Race (NIH/OMB)
More than one race
0 eyes
n=25 eyes
0 eyes
n=25 eyes
0 eyes
n=50 eyes
Race (NIH/OMB)
Unknown or Not Reported
0 eyes
n=25 eyes
0 eyes
n=25 eyes
0 eyes
n=50 eyes
Region of Enrollment
United States
25 eyes
n=25 eyes
25 eyes
n=25 eyes
50 eyes
n=50 eyes
Diagnosis
Fuch's Dystrophy
24 eyes
n=25 eyes
24 eyes
n=25 eyes
48 eyes
n=50 eyes
Diagnosis
Pseudophakic Bullous Keratopathy
1 eyes
n=25 eyes
1 eyes
n=25 eyes
2 eyes
n=50 eyes
Best Spectacle-Corrected Visual Acuity (logMAR)
0.27 logMAR
STANDARD_DEVIATION 0.21 • n=25 eyes
0.34 logMAR
STANDARD_DEVIATION 0.29 • n=25 eyes
0.30 logMAR
STANDARD_DEVIATION 0.25 • n=50 eyes
Surgery
Pseudophakic Endothelial Keratoplasty
8 eyes
n=25 eyes
7 eyes
n=25 eyes
15 eyes
n=50 eyes
Surgery
Triple Endothelial Keratoplasty
17 eyes
n=25 eyes
18 eyes
n=25 eyes
35 eyes
n=50 eyes
Donor Age
64 years
n=25 eyes
62 years
n=25 eyes
63 years
n=50 eyes
Donor Sex
Female
8 eyes
n=25 eyes
5 eyes
n=25 eyes
13 eyes
n=50 eyes
Donor Sex
Male
17 eyes
n=25 eyes
20 eyes
n=25 eyes
37 eyes
n=50 eyes
Donor Death to Preservation Time
9 hours
STANDARD_DEVIATION 4 • n=25 eyes
9 hours
STANDARD_DEVIATION 3 • n=25 eyes
9 hours
STANDARD_DEVIATION 4 • n=50 eyes
Donor Death to Surgery Time
6 days
STANDARD_DEVIATION 1 • n=25 eyes
6 days
STANDARD_DEVIATION 1 • n=25 eyes
6 days
STANDARD_DEVIATION 1 • n=50 eyes
Donor Endothelial Cell Count (pre-processing)
2792 cells/mm^2
STANDARD_DEVIATION 210 • n=25 eyes
2797 cells/mm^2
STANDARD_DEVIATION 222 • n=25 eyes
2795 cells/mm^2
STANDARD_DEVIATION 214 • n=50 eyes
Donor Endothelial Cell Count (post-processing)
2796 cells/mm^2
STANDARD_DEVIATION 238 • n=25 eyes
2771 cells/mm^2
STANDARD_DEVIATION 150 • n=25 eyes
2783 cells/mm^2
STANDARD_DEVIATION 197 • n=50 eyes
Donor Central Graft Thickness (UT-DSAEK only)
73 mm
n=25 eyes
NA mm
n=25 eyes
73 mm
n=50 eyes
Central Corneal Thickness
610 microns
STANDARD_DEVIATION 44 • n=24 eyes • missing one value
608 microns
STANDARD_DEVIATION 52 • n=25 eyes • missing one value
609 microns
STANDARD_DEVIATION 48 • n=49 eyes • missing one value
Spherical Equivalent
-0.4 diopters
STANDARD_DEVIATION 1.9 • n=25 eyes
-0.8 diopters
STANDARD_DEVIATION 2.2 • n=25 eyes
-0.6 diopters
STANDARD_DEVIATION 2.0 • n=50 eyes

PRIMARY outcome

Timeframe: 6 months

Population: One patient lost to followup

The BSCVA was recorded at 4 meters by a masked refractionist certified for the study using a protocol adapted from the Age-Related Eye Disease Study using Early Treatment Diabetic Retinopathy Study charts: chart R(2110), chart 1(2111), and chart 2(2112) (Precision Vision, Woodstock, IL).

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=25 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=24 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Best Spectacle-Corrected Visual Acuity
0.22 logMAR
Standard Deviation 0.16
0.05 logMAR
Standard Deviation 0.11

SECONDARY outcome

Timeframe: 3 and 12 months

The BSCVA was recorded at 4 meters by a masked refractionist certified for the study using a protocol adapted from the Age-Related Eye Disease Study using Early Treatment Diabetic Retinopathy Study charts: chart R(2110), chart 1(2111), and chart 2(2112) (Precision Vision, Woodstock, IL).

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=25 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Best Spectacle-Corrected Visual Acuity
3 Months
0.24 logMAR
Standard Deviation 0.21
0.11 logMAR
Standard Deviation 0.13
Best Spectacle-Corrected Visual Acuity
12 Months
0.16 logMAR
Standard Deviation 0.18
0.04 logMAR
Standard Deviation 0.12

SECONDARY outcome

Timeframe: 24 Months

The BSCVA was recorded at 4 meters by a masked refractionist certified for the study using a protocol adapted from the Age-Related Eye Disease Study using Early Treatment Diabetic Retinopathy Study charts: chart R(2110), chart 1(2111), and chart 2(2112) (Precision Vision, Woodstock, IL).

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=25 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Best Spectacle-Corrected Visual Acuity
0.15 LogMar
Standard Deviation 0.15
0.09 LogMar
Standard Deviation 0.16

SECONDARY outcome

Timeframe: 3, 6, 12 months

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=25 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Endothelial Cell Count
3 Months
2114 cells/mm^2
Standard Deviation 357
2037 cells/mm^2
Standard Deviation 495
Endothelial Cell Count
6 Months
2113 cells/mm^2
Standard Deviation 301
1963 cells/mm^2
Standard Deviation 425
Endothelial Cell Count
12 Months
2070 cells/mm^2
Standard Deviation 292
1855 cells/mm^2
Standard Deviation 448

SECONDARY outcome

Timeframe: 24 months

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=25 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Endothelial Cell Count
1626 cells/mm^2
Standard Deviation 362
1400 cells/mm^2
Standard Deviation 498

SECONDARY outcome

Timeframe: 3, 6, 12 months

Corneal anterior and posterior surface higher-order aberrations (HOA) were measured with Scheimpflug imaging (Pentacam) before surgery and at 3, 6, and 12 months post-operatively. Zernike orders 3-8 were calculated at 4.0- and 6.0-mm-diameter optical zones. The results reported here represent total HOA (Sum of Zernike orders 3-8). Note a single observation was not available for one eye in the DMEK group at 6 months, this was analyzed with last observation carried forward.

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=19 Participants
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Corneal Higher-Order Aberrations
3 Months Anterior Cornea 4.0-mm
0.274 root mean square in micrometers
Standard Deviation 0.223
0.288 root mean square in micrometers
Standard Deviation 0.104
Corneal Higher-Order Aberrations
3 Months Posterior Cornea 4.0-mm
0.217 root mean square in micrometers
Standard Deviation 0.110
0.116 root mean square in micrometers
Standard Deviation 0.056
Corneal Higher-Order Aberrations
3 Months Anterior Cornea 6.0-mm
0.897 root mean square in micrometers
Standard Deviation 0.800
0.829 root mean square in micrometers
Standard Deviation 0.367
Corneal Higher-Order Aberrations
3 Months Posterior Cornea 6.0-mm
0.621 root mean square in micrometers
Standard Deviation 0.308
0.346 root mean square in micrometers
Standard Deviation 0.153
Corneal Higher-Order Aberrations
6 Months Anterior Cornea 4.0-mm
0.230 root mean square in micrometers
Standard Deviation 0.110
0.243 root mean square in micrometers
Standard Deviation 0.100
Corneal Higher-Order Aberrations
6 Months Posterior Cornea 4.0-mm
0.179 root mean square in micrometers
Standard Deviation 0.067
0.095 root mean square in micrometers
Standard Deviation 0.031
Corneal Higher-Order Aberrations
6 Months Anterior Cornea 6.0-mm
0.739 root mean square in micrometers
Standard Deviation 0.371
0.724 root mean square in micrometers
Standard Deviation 0.337
Corneal Higher-Order Aberrations
6 Months Posterior Cornea 6.0-mm
0.505 root mean square in micrometers
Standard Deviation 0.217
0.288 root mean square in micrometers
Standard Deviation 0.089
Corneal Higher-Order Aberrations
12 Months Anterior Cornea 4.0-mm
0.228 root mean square in micrometers
Standard Deviation 0.108
0.241 root mean square in micrometers
Standard Deviation 0.100
Corneal Higher-Order Aberrations
12 Months Posterior Cornea 4.0-mm
0.159 root mean square in micrometers
Standard Deviation 0.068
0.098 root mean square in micrometers
Standard Deviation 0.028
Corneal Higher-Order Aberrations
12 Months Anterior Cornea 6.0-mm
0.725 root mean square in micrometers
Standard Deviation 0.344
0.723 root mean square in micrometers
Standard Deviation 0.328
Corneal Higher-Order Aberrations
12 Months Posterior Cornea 6.0-mm
0.459 root mean square in micrometers
Standard Deviation 0.206
0.284 root mean square in micrometers
Standard Deviation 0.073

SECONDARY outcome

Timeframe: 24 months

As measured by Pentacam

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=25 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Corneal Higher-Order Aberrations
24 Months Anterior Cornea 4.0-mm
0.215 root mean square in micrometers
Standard Deviation 0.136
0.211 root mean square in micrometers
Standard Deviation 0.008
Corneal Higher-Order Aberrations
24 Months Posterior Cornea 4.0-mm
0.155 root mean square in micrometers
Standard Deviation 0.075
0.086 root mean square in micrometers
Standard Deviation 0.029
Corneal Higher-Order Aberrations
24 Months Anterior Cornea 6.0-mm
0.707 root mean square in micrometers
Standard Deviation 0.389
0.679 root mean square in micrometers
Standard Deviation 0.314
Corneal Higher-Order Aberrations
24 Months Posterior Cornea 6.0-mm
0.450 root mean square in micrometers
Standard Deviation 0.216
0.260 root mean square in micrometers
Standard Deviation 0.008

SECONDARY outcome

Timeframe: 3, 6, 12 months

As measured by Pentacam densitometry

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=25 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Interface Haze
Mild Interface Haze at 3 months
2 eyes
1 eyes
Interface Haze
Moderate Interface Haze at 3 months
0 eyes
0 eyes
Interface Haze
Severe Interface Haze at 3 months
0 eyes
0 eyes
Interface Haze
Mild Interface Haze at 6 months
2 eyes
1 eyes
Interface Haze
oderate Interface Haze at 6 months
1 eyes
0 eyes
Interface Haze
Severe Interface Haze at 6 months
0 eyes
0 eyes
Interface Haze
Mild Interface Haze at 12 months
0 eyes
0 eyes
Interface Haze
oderate Interface Haze at 12 months
0 eyes
0 eyes
Interface Haze
Severe Interface Haze at 12 months
0 eyes
0 eyes

SECONDARY outcome

Timeframe: 24 months

As measured by Pentacam densitometry

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=25 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Interface Haze
Moderate Interface Haze at 24 months
1 eyes
0 eyes
Interface Haze
Severe Interface Haze at 24 months
0 eyes
0 eyes
Interface Haze
Mild Interface Haze at 24 months
0 eyes
0 eyes

SECONDARY outcome

Timeframe: Baseline, 12 months

Population: For this analysis, all "second eyes" (enrolled eyes belonging to a patient that had enrolled their other eye and already had surgery on that eye as part of this study) were removed. For this reason the total number of eyes equals the total number of participants.

The National Eye Institute has developed the validated Visual Functioning Questionnaire (NEI-VFQ) to assess the effect of ocular conditions and vision on patient quality of life. The answers to the questionnaire are transformed into sub-scales, including: general health, general vision, ocular pain, near activities, distance activities, social functioning, mental health, role difficulties, dependency, driving, color vision, peripheral vision. Participants are assigned a numerical value for each sub-scale based on their answers between 0-100, where higher numbers indicate better visual function. These sub-scales are then combined according to National Eye Institute guidelines into an overall composite score for each participant. This overall composite score is also on a scale of 0-100, where higher numbers indicate better visual function. Composite score based on National Eye Institute guidelines.

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=19 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=19 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
National Eye Institute - Visual Functioning Questionnaire (NEI-VFQ)
Baseline
72.5 Composite scores on a scale
Standard Deviation 13.4
72.3 Composite scores on a scale
Standard Deviation 15.2
National Eye Institute - Visual Functioning Questionnaire (NEI-VFQ)
12 Months
85.9 Composite scores on a scale
Standard Deviation 9.1
87.3 Composite scores on a scale
Standard Deviation 9.5

SECONDARY outcome

Timeframe: Baseline 12 months

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=25 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Graft Failure/Graft Rejection
Graft Rejection
0 eyes
0 eyes
Graft Failure/Graft Rejection
Graft Failure
1 eyes
1 eyes

SECONDARY outcome

Timeframe: Baseline to 24 months

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=25 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Graft Failure/Graft Rejection
Graft Rejection
0 eyes
0 eyes
Graft Failure/Graft Rejection
Graft Failure
1 eyes
1 eyes
Graft Failure/Graft Rejection
Eyes with No Graft Failure or Rejection
24 eyes
24 eyes

OTHER_PRE_SPECIFIED outcome

Timeframe: 3, 6, 12, 24 months

Manifest refraction using phoropter

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 3, 6, 12, 24 months

As measured by Optical coherence tomography (OCT) and Pachymetry

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=25 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Graft Thickness
3 months
589.36 root mean square in micrometers
Interval 568.4 to 614.5
516.5 root mean square in micrometers
Interval 499.4 to 533.35
Graft Thickness
6 months
592.24 root mean square in micrometers
Interval 573.92 to 612.84
519.67 root mean square in micrometers
Interval 504.75 to 533.88
Graft Thickness
12 months
585.96 root mean square in micrometers
Interval 569.32 to 603.12
521.36 root mean square in micrometers
Interval 506.28 to 536.32
Graft Thickness
24 months
593.67 root mean square in micrometers
Interval 577.08 to 612.21
526.88 root mean square in micrometers
Interval 512.2 to 541.28

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 3, 6, 12, 24 months

composite measure

Outcome measures

Outcome measures
Measure
UT-DSAEK
n=25 eyes
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 eyes
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Adverse Events/Complication Rates
Adverse Events at 3 months
4 new adverse events reported
6 new adverse events reported
Adverse Events/Complication Rates
Adverse Events at 6 months
4 new adverse events reported
5 new adverse events reported
Adverse Events/Complication Rates
Adverse Events at 12 months
1 new adverse events reported
4 new adverse events reported
Adverse Events/Complication Rates
Adverse Events at 24 months
0 new adverse events reported
0 new adverse events reported

Adverse Events

UT-DSAEK

Serious events: 0 serious events
Other events: 9 other events
Deaths: 0 deaths

DMEK

Serious events: 0 serious events
Other events: 7 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
UT-DSAEK
n=25 participants at risk
Type of corneal transplant; Tissue grafts will be cut to the right thickness using a microkeratome prepared at the eye bank per standard eye bank protocol (about 60-90 microns thick). A 4 mm corneal incision will be used, with Endoserter as the means of inserting the graft, an FDA approved device for this purpose. UT-DSAEK Endoserter: The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument. Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
DMEK
n=25 participants at risk
Type of corneal transplant; Endothelial grafts will be pre-peeled at the eyebank (70%). In the operating room the remaining 30% will be peeled, and the endothelium will be stained with trypan blue. A 3.5 mm corneal incision will be used and the graft will be inserted with a modified jones tube injector. The tap technique will be used to position the graft. DMEK Prednisolone: Prednisolone is a corticosteroid used to alleviate swelling post-surgery. Ofloxacin: Ofloxacin is an antibiotic used to treat bacterial infections of the eye. Tropicamide: Tropicamide is a prescription drug used to dilate pupils during an eye exam. Phenylephrine: Phenylephrine is a prescription drug used to dilate pupils during an eye exam. Jones Tube: The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Eye disorders
Glaucoma (nonsurgical)
8.0%
2/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
8.0%
2/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Glaucoma (surgical)
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Graft displacement
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
0.00%
0/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Graft failure
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Graft rejection
0.00%
0/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
0.00%
0/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Infectious keratitis
0.00%
0/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
0.00%
0/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Posterior synechiae
0.00%
0/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Re-bubble
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
24.0%
6/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Retinal tear
0.00%
0/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Visually significant central epithelial opacity
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
0.00%
0/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Intralocular lens repositioning
0.00%
0/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Epiretinal membrane and lamellar hole
0.00%
0/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Cystoid macular edema
0.00%
0/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Visual disturbance
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
Eye disorders
Postoperative day 1 pupillary block
4.0%
1/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).
0.00%
0/25 • 24 months
Adverse events are reported by eye (N = 50), not by participant (N = 38).

Additional Information

Dr. Jennifer Rose-Nussbaumer

Kaiser Permanente / University of California, San Francisco

Phone: 650-299-2111

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place